Langer-Gould A - Search Results

1

Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies.

Luna G, Alping P, Burman J, Fink K, Fogdell-Hahn A, Gunnarsson M, Hillert J, Langer-Gould A, Lycke J, Nilsson P, Salzer J, Svenningsson A, Vrethem M, Olsson T, Piehl F, Frisell T. Luna G, et al. JAMA Neurol. 2020 Feb 1;77(2):184-191. doi: 10.1001/jamaneurol.2019.3365. JAMA Neurol. 2020. PMID: 31589278 Free PMC article.

2

Vitamin D levels in Hispanics with multiple sclerosis.

Amezcua L, Chung RH, Conti DV, Langer-Gould AM. Amezcua L, et al. J Neurol. 2012 Dec;259(12):2565-70. doi: 10.1007/s00415-012-6537-z. Epub 2012 May 16. J Neurol. 2012. PMID: 22588255

3

Childhood obesity and risk of pediatric multiple sclerosis and clinically isolated syndrome.

Langer-Gould A, Brara SM, Beaber BE, Koebnick C. Langer-Gould A, et al. Neurology. 2013 Feb 5;80(6):548-52. doi: 10.1212/WNL.0b013e31828154f3. Epub 2013 Jan 30. Neurology. 2013. PMID: 23365063 Free PMC article.

4

Incidence of multiple sclerosis in multiple racial and ethnic groups.

Langer-Gould A, Brara SM, Beaber BE, Zhang JL. Langer-Gould A, et al. Neurology. 2013 May 7;80(19):1734-9. doi: 10.1212/WNL.0b013e3182918cc2. Neurology. 2013. PMID: 23650231

5

Spinal cord lesions and disability in Hispanics with multiple sclerosis.

Amezcua L, Lerner A, Ledezma K, Conti D, Law M, Weiner L, Langer-Gould A. Amezcua L, et al. J Neurol. 2013 Nov;260(11):2770-6. doi: 10.1007/s00415-013-7054-4. Epub 2013 Aug 3. J Neurol. 2013. PMID: 23912723 Free PMC article.

6

The pill times 2: what every woman with multiple sclerosis should know.

Langer-Gould AM. Langer-Gould AM. Neurology. 2014 Feb 25;82(8):654-5. doi: 10.1212/WNL.0000000000000155. Epub 2014 Jan 24. Neurology. 2014. PMID: 24463629 No abstract available.

7

The incidence of clinically isolated syndrome in a multi-ethnic cohort.

Langer-Gould A, Brara SM, Beaber BE, Zhang JL. Langer-Gould A, et al. J Neurol. 2014 Jul;261(7):1349-55. doi: 10.1007/s00415-014-7349-0. Epub 2014 Apr 29. J Neurol. 2014. PMID: 24777692

8

Natalizumab use during the third trimester of pregnancy.

Haghikia A, Langer-Gould A, Rellensmann G, Schneider H, Tenenbaum T, Elias-Hamp B, Menck S, Zimmermann J, Herbstritt S, Marziniak M, Kümpfel T, Meinl I, Plavina T, Gold R, Hellwig K. Haghikia A, et al. JAMA Neurol. 2014 Jul 1;71(7):891-5. doi: 10.1001/jamaneurol.2014.209. JAMA Neurol. 2014. PMID: 24821217 Review.

9

Vaccines and the risk of multiple sclerosis and other central nervous system demyelinating diseases.

Langer-Gould A, Qian L, Tartof SY, Brara SM, Jacobsen SJ, Beaber BE, Sy LS, Chao C, Hechter R, Tseng HF. Langer-Gould A, et al. JAMA Neurol. 2014 Dec;71(12):1506-13. doi: 10.1001/jamaneurol.2014.2633. JAMA Neurol. 2014. PMID: 25329096

10

The pill times 2: what every woman with multiple sclerosis should know.

Henson LJ, Cavalier S, Langer-Gould AM. Henson LJ, et al. Neurology. 2014 Oct 28;83(18):1685. doi: 10.1212/01.wnl.0000456505.44996.b4. Neurology. 2014. PMID: 25349277 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

106 results

Search Page